In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Cancer Type/Condition:  Ewing sarcoma/PNET
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: CDR0000068608, EURO-EWING-INTERGROUP-EE99, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, EU-20213, AEWS0331, NCT00020566

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01412, CDR0000680558, MSKCC-10049, 10-049, 8406, N01CM62206, P30CA008748, U01CA069856, NCT01154452

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and over
Sponsor: NCI
Protocol IDs: 120135, 12-C-0135, NCT01610570

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 months to 30 years
Sponsor: NCI
Protocol IDs: NCI-2014-00804, ADVL1411, UM1CA097452, NCT02116777

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 13 moths to 29 years
Sponsor: NCI, Other
Protocol IDs: 2013-171, NCI-2014-01149, P30CA022453, NCT02173093

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: 05-326, Other, NCT00592293

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2011-02605, CDR0000686608, COG-ACNS0821, ACNS0821, U10CA098543, NCT01217437

9.

Phase: Phase I
Type: Treatment
Status: Active
Age: 2 to 25
Sponsor: NCI, Other
Protocol IDs: CDR0000257582, UIHC-200008086, NCI-V02-1710, 200008086, NCT00049023

10.

Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 03-133, P30CA008748, MSKCC-03133, NCT00089245

11.

Phase: Phase I
Type: Treatment
Status: Active
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 110073, 11-C-0073, NCT01287104

12.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01165, CDR0000737378, 12-083, 9172, U01CA069856, P30CA008748, NCT01643278

13.

Phase: Phase I
Type: Treatment
Status: Active
Age: 35 and under
Sponsor: NCI
Protocol IDs: 140059, 14-C-0059, NCT02107963

14.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Genetics, Natural history/Epidemiology
Status: Active
Age: 1 month to 95 years
Sponsor: NCI
Protocol IDs: NCI-78-C-0039, NCT00004007

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 21 and under at diagnosis, any age at study entry
Sponsor: NCI, Other
Protocol IDs: ALTE03N1, NCI-2011-03822, COG-ALTE03N1, CDR0000360708, U10CA095861, NCT00082745

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000478867, COG-ABTR04B1, ABTR04B1, NCT00898755

17.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: AEWS07B1, NCI-2009-00370, COG-AEWS07B1, CDR0000544202, U10CA098543, NCT00899990

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554417, JHOC-J0685, NA_00003073, J0685, NCT00499733

19.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 10 and over
Sponsor: NCI, Other
Protocol IDs: 15198, P50AR054041, NCT00594776

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: CCSS, U24CA055727, R03CA169150, R01CA134722, R01CA136783, R01CA132899, NCT01120353

21.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 6 months to 40 years
Sponsor: NCI, Other
Protocol IDs: 12391, NCI-2013-00439, NCT01795430

22.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 3 months to 40 years
Sponsor: NCI
Protocol IDs: 980037, 98-C-0037, NCT00001686

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: AEPI10N5, NCI-2012-02210, U10CA098543, NCT01876303
New Search